Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology

@article{McCullough1998AlcoholicLD,
  title={Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology},
  author={Arthur J. McCullough and J Connor},
  journal={American Journal of Gastroenterology},
  year={1998},
  volume={93},
  pages={2022-2036}
}
Objective:The objective of this work was to develop practice guidelines for the management of alcoholic liver disease.Method:A computerized search using the Medline Data Base from 1966–July 1997 was performed with the search headings; alcohol, alcoholic hepatitis, alcoholic liver disease, liver transplant, diagnosis, epidemiology, human, and English only. All randomized controlled trials, case-control studies, and meta-analyses were read in depth. A manual search was also done using references… 

Figures and Tables from this paper

Glucocorticosteroids Are Not Effective in Alcoholic Hepatitis

The evidence does not support the contention that glucocorticosteroids should be recommended for the treatment of patients with alcoholic hepatitis, including those with hepatic encephalopathy, and meta-analysis based on fixed-effects methods is not valid.

Alcoholic hepatitis: from pathogenesis to treatment

The current state in diagnosis and management of alcoholic hepatitis is summarized and the latest advances in pathophysiology that may lead to new therapeutic strategies for this difficult clinical condition are reviewed.

Controversies in the management of alcoholic liver disease.

In patients with severe hepatitis, there appears to be a moderate survival benefit from the use of either corticosteroids or pentoxifylline in the absence of contraindications to their use, and orthotopic liver transplantation remains the definitive therapy for decompensated alcoholic cirrhosis despite alcohol abstinence.

Pentoxifylline for alcoholic hepatitis.

The current available data may indicate a possible positive intervention effect of pentoxifylline on all-cause mortality and mortality due to hepatorenal syndrome, and conversely, an increase in serious and non-serious adverse events.

Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy.

It is concluded that the routine use of glucocorticoids for severe AH poses significant risk with equivocal benefit, and that pentoxifylline is a better, safer and cheaper alternative.

How useful and accurate is the new Glasgow alcoholic hepatitis scoring system?

  • T. Morgan
  • Medicine
    Nature Clinical Practice Gastroenterology &Hepatology
  • 2006
The Glasgow Alcoholic Hepatitis Score (GAHS) was developed on the basis of data collected in this prospective, multicenter study on patients with alcoholic liver disease, a serum bilirubin level ≥80 μmol/l and a history of excessive alcohol ingestion ≥3 weeks before hospital admission.

, MD , FACP Alcoholic Hepatitis

The fundamental aspects of diagnosis, prognosis, and management of acute alcoholic hepatitis are reviewed, with considerable data suggesting that the amount of alcohol consumed and the duration of consumption on an individual basis relates to the risk of ALD.

The Epidemiology and Clinical Characteristics of Patients With Newly Diagnosed Alcohol-related Liver Disease: Results From Population-based Surveillance

Patients with alcoholic liver disease may present at a late stage and may not identify alcohol as a cause for their liver disease, and improved patient screening and education may limit morbidity and mortality.

Long-Term Management of Alcoholic Liver Disease.

Focus on alcoholic liver disease: from nosography to treatment.

Abusive alcohol intake currently ranks as a major cause of liver disease, and is associated with significant mortality worldwide. Alcoholic liver disease (ALD) generically defines liver abnormalities
...

References

SHOWING 1-10 OF 213 REFERENCES

Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials.

It is suggested that corticosteroids reduce short-term mortality in patients with acute alcoholic hepatitis who have hepatic encephalopathy, that the protective effect depends on the exclusion criterion of acute gastrointestinal bleeding and is influenced by trial quality, and that cortiosteroids are of no benefit in patients without hepaticEncephalopathy.

Alcoholic hepatitis superimposed on cirrhosis. Clinical significance and effect of long-term prednisone treatment.

Of 483 patients with biopsy-verified cirrhosis who entered the controlled trial of prednisone treatment conducted by the Copenhagen Study Group for Liver Diseases, 99 had alcoholic hepatitis as

A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients.

In a prospective double-blind study, 27 patients with alcoholic hepatitis were randomized for 6-methylprednisolone or placebo treatment and the role of liver biopsy feasibility at selection is emphasized.

Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables.

The results do not support the routine use of glucocorticoids in patients with alcoholic hepatitis, including those with encephalopathy, but whether other subgroups may benefit needs further investigation using the individual patient data from the published trials and testing in new randomised trials.

Can't treat, won't treat? Alcoholic liver disease

In patients with severe alcoholic hepatitis, specific therapies such as high dose corticosteroids and propylthiouracil have shown promising results but are still under evaluation, but whether a minimum period of abstinence should be a requirement remains the subject of debate.

Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?

The cause of chronic liver disease is best elucidated when the noninvasive work-up is complemented by review of a biopsy specimen.

Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy.

Based on the results of the two largest, long-term studies, the use of oral branched-chain amino acids in the prevention and treatment of chronic encephalopathy may only be proposed for patients with advanced cirrhosis, intolerant to alimentary proteins.

Clinicopathological analysis of alcoholic liver disease complicating chronic type C hepatitis.

Comparison of histological changes of liver needle biopsies, Chiron C100 antibody (C-100) for hepatitis C virus, as well as clinical and laboratory data revealed that there were significant differences in Gamma-glutamyl transpeptidase, gamma-globulin, and adenosine deaminase levels in the sera between the ALD alone and theALD complicating NANB chronic hepatitis groups.
...